BioMark Diagnostics Inc.
BUX
Kedudukan dalam Saham
#26652
BioMark Diagnostics Inc. is an oncology specialist, developing advanced... BioMark Diagnostics Inc. is an oncology specialist, developing advanced diagnostic tools for cancer to enable early detection, continuous patient monitoring, and the assessment of initial treatment efficacy. The firm holds a research partnership with the Icahn School of Medicine, collaborating on clinical trials specifically addressing the early identification of lung cancer. Founded in 2014, its corporate headquarters are situated in Richmond, Canada. BioMark Diagnostics Inc. operates as a subsidiary of Biomark Technologies Inc.
Harga Saham
$0.34495034
Disegerakkan terakhir: 2026-10-16
Modal Pasaran
$36.73M
Perubahan (1 hari)
-4.08%
Perubahan (1 tahun)
53.78%
Negara
CA
Perdagangan BioMark Diagnostics Inc. (BUX)
Kategori
Healthcare
Modal pasaran bagi BioMark Diagnostics Inc.(BUX)
Modal Pasaran: $36.73M
Sehingga October 2026, BioMark Diagnostics Inc. mempunyai modal pasaran sebanyak $36.73M. Ini menjadikan BioMark Diagnostics Inc. syarikat ke-26652nd paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran BioMark Diagnostics Inc. dari 2015 hingga 2026
BUX berbanding dengan 5 teratas yang paling popular stocks
